| Name | Title | Contact Details |
|---|
MSU Health Care is the multi-specialty medical practice of Michigan State University, with approximately 300 physicians, nurse practitioners and physician assistants. Our providers are university researchers and academic professors, spanning 25 adult and pediatric specialties. Our commitment to education allows our providers to teach future medical professionals and participate in research. Our large clinical practice connects you to the latest medical advancements, including opportunities to participate in clinical trials. Our providers practice at office locations throughout the greater Lansing area and serve patients from Mid-Michigan, and beyond. The largest clinical practice location is the MSU Clinical Center, situated on the MSU campus in East Lansing. Our locations offer multiple primary and specialty services, as well as a pharmacy, laboratory and radiology services. Our providers also treat patients at McLaren Greater Lansing and Sparrow Hospitals, in addition to several outlying community hospitals, nursing homes, rehabilitation centers, wound care centers, and Ingham County Health Department clinics.
Carelon is a healthcare services company that provides connected healthcare solutions for better outcomes and experiences.
Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.
Path is a healthcare company powered by technology. We`re a teletherapy company that doesn`t compromise on quality — we measure progress and prioritize patient outcomes. Path takes a patient-first approach, where treatment is more accessible, personalized, and effective. With Path, it`s easy to find a high-quality therapist or psychiatric practitioner who meets your unique needs, accepts insurance, and is taking new patients. For providers, Path offers the flexibility of private practice, while also filling caseloads and offering the necessary behind-the-scenes support. Path handles the marketing, credentialing, billing, and admin tasks so providers can focus on what they love: providing care to those in need. With no minimum caseload required and guaranteed payments, Path is a trusted partner for more than 8,000 therapists nationwide and has hundreds of 5-star reviews. Our mission is to make mental healthcare work for everyone. Path is a 100% remote healthtech company and we`re hiring! We have teams who specialize in the areas of Clinical, Finance, Operations, Marketing, Engineering, Product, and more. We`re excited to bring people onto the team who are committed to changing how mental health is treated.
Advanced Biomedical Research is a Princeton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.